Latest News for: xrn1

Edit

Accent Therapeutics Unveils XRN1 Program and Provides Pipeline Update with Presentations at 35th AACR-NCI-EORTC Symposium

The Galveston Daily News 10 Oct 2023
Company developing potent and selective small molecule inhibitors of XRN1, a compelling oncology target to address tumors with high interferon signaling ... 5′→3′ exoribonuclease 1 (XRN1) is an enzyme ...
  • 1

Article Search

tools

Most Viewed

×
×
×
×